OpenEvidence
头部巨兽为医生及其他医疗专业人员提供基于医学文献的 AI 临床决策支持,并辅助生成诊疗记录与编码建议。
- 月访问
- 15.2M
- 上升5.8%环比2026 年 10 月
- 公开收入
- 未公开
- 暂无公开收入证据
- 入门价
- 免费
- 没有月付订阅价
- 首次发布
- 2 年前
- 2024-08-15 · 估算
访问
营销动作
发布、搜索与内容、引荐、促销OpenEvidence 与 ACP 合作,整合临床指南产品动态
ACP 的临床指南和 Annals of Internal Medicine 正在整合到 OpenEvidence 中,以便为医生提供附有引文的答案。
11 月 9 日 · 12 天前X 原帖
当时 月访问 15.2M在 Google Play 发布发布
OpenEvidence provides accurate answers at the point of care (NPI REQUIRED)
2024 年 9 月 30 日 · 2 年前发布页
在 App Store 发布发布
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of c
2024 年 8 月 15 日 · 2 年前发布页
商店数据
- 评分
- ★ 4.9211.4K 个评分
- 价格与内购
- 免费
- 当前版本
- v2.9.2091 MB
- 首次上架
- 2024-08-15
* NEJM, JAMA, and NCCN content partnership * Streamlined experience during answer writing * Performance enhancements
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide. Now sourcing from over 300+ medical journals, as well as the FDA and CDC. OpenEvidence is an official AI partner of The New England Journal of Medicine and the Journal of American Medical Association (and their 11 specialty journals), and has content agreements, partnerships and collaborations with: NCCN ACC ADA ACEP AAFP AAOS AAOHNS and more. OpenEvidence is only available for health care professionals. Users must verify their health care professional status before using OpenEvidence. TESTIMONIALS “I've been using OpenEvidence for the last week - it has been amazing! Able to narrow down on results quickly and find information that I wasn't able to do with Google/PubMed searches on my own.” - Dr. John Lee, MD. Physician & Faculty Member, Harvard Medical School “OpenEvidence can be the foundational technology to power all clinical decision tools.” - Dr. Antonio Jorge Forte, MD. Director of MayoExpert, Mayo Clinic “OpenEvidence is more up-to-date than UpToDate. And more useful regardless, since it’s interactive, and you can ask it questions, and get very specific answers about specific medical fact patterns in a patient case. It’s like having a curbside consult with a team of expert physicians, but that you can carry around with you in your pocket.” - Dr. Ram Dandillaya, MD. Clinical Chief, Department of Cardiology, Cedars-Sinai Medical Center “I am in community practice and medical director of a community cancer center. OpenEvidence has been an incredible lifeline for daily practitioners.” - C.J., Oncologist “OpenEvidence is absolutely fantastic. I use it a gazillion times a day.” - J.A., Neurologist “OpenEvidence’s efforts to make medicine more evidence-based are invaluable. The shift from judgment to calculation can reduce the level of noise currently found in medicine.” - Daniel Kahneman, Nobel Prize Laureate (In Memoriam) “It is light years ahead of the next best medical oriented AI I have used.” - R.E.., Oncologist
OpenEvidence provides accurate answers at the point of care (NPI REQUIRED)
- 评分
- ★ 4.864,377 个评分
- 安装规模
- 100,000+至少 100K 次安装
- 价格与内购
- 免费无内购
- 当前版本
- v2.9.19
* NEJM, JAMA, and NCCN content partnership * Streamlined experience during answer writing * Performance enhancements
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide. Now sourcing from over 300+ medical journals, as well as the FDA and CDC. OpenEvidence is an official AI partner of The New England Journal of Medicine and the Journal of American Medical Association (and their 11 specialty journals), and has content agreements, partnerships and collaborations with: • NCCN • ACC • ADA • ACEP • AAFP • AAOS • AAOHNS and more. OpenEvidence is only available for health care professionals. Users must verify their health care professional status before using OpenEvidence. TESTIMONIALS “I've been using OpenEvidence for the last week - it has been amazing! Able to narrow down on results quickly and find information that I wasn't able to do with Google/PubMed searches on my own.” - Dr. John Lee, MD. Physician & Faculty Member, Harvard Medical School “OpenEvidence can be the foundational technology to power all clinical decision tools.” - Dr. Antonio Jorge Forte, MD. Director of MayoExpert, Mayo Clinic “OpenEvidence is more up-to-date than UpToDate. And more useful regardless, since it’s interactive, and you can ask it questions, and get very specific answers about specific medical fact patterns in a patient case. It’s like having a curbside consult with a team of expert physicians, but that you can carry around with you in your pocket.” - Dr. Ram Dandillaya, MD. Clinical Chief, Department of Cardiology, Cedars-Sinai Medical Center “I am in community practice and medical director of a community cancer center. OpenEvidence has been an incredible lifeline for daily practitioners.” - C.J., Oncologist “OpenEvidence is absolutely fantastic. I use it a gazillion times a day.” - J.A., Neurologist “OpenEvidence’s efforts to make medicine more evidence-based are invaluable. The shift from judgment to calculation can reduce the level of noise currently found in medicine.” - Daniel Kahneman, Nobel Prize Laureate (In Memoriam) “It is light years ahead of the next best medical oriented AI I have used.” - R.E.., Oncologist
商店图标、评分分布、安装量级与宣传截图来自 Apple App Store、Google Play 与 Chrome 应用商店公开页面。
流量来源
访问构成
这个网站的访问渠道与国家构成还没有数据。
搜索
站点权重 —域名注册 2004-01-02
这个网站还没有搜索关键词数据。
流量数据:Vaneform
定价
尚未识别出定价页,或该页面没有公开价格。
官网快照
关键页面
桌面端与移动端存档官网快照待采集。
问题与证据
- OpenEvidence 的网站访问量是多少?
- Vaneform 估算 2026-10 网站访问量为 15.2M。访问量包含重复访问,付费客户数与收入需分别查看对应证据。来源
- OpenEvidence 是什么产品,支持哪些平台?
- OpenEvidence 归属「医疗与护理机构」赛道:为医生及其他医疗专业人员提供基于医学文献的 AI 临床决策支持,并辅助生成诊疗记录与编码建议。 支持平台包括:移动应用。
同分类研究对象
这些产品属于同一目录分类。选型时请进一步核对客户任务、功能与部署要求。